Sensemedic in Hong Kong
Evalan started delivering Sensemedic services in Hong Kong to lung cancer patients.
Healthcare
ITEA Award of Excellence
Evalan has received the ITEA Award of Excellence. ITEA recognized Evalan for its management of a large innovation project, the MoSHCA project, that focused on the development of solutions for patient self-management and treatment of patients at home. This project was executed in a consortium with 10 partners from 5 countries, consisting of universities, companies and knowledge institutes.
FDA Approval Sensemedic for US
Evalan has received approval from the US Food and Drug Administration (FDA) to distribute and sell Sensemedic to the US market. Sensemedic has been available in Europe, Asia and Africa since 2007 and will now also be available in the US. Support patients towards a better intake pattern Sensemedic is smart medication reminding system that …
European Grant for SensiStep
The UMC Utrecht and Evalan BV have secured European funding for the COMFORT project within the Eurostars Program.
